These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23792286)

  • 1. Lack of endogenous opioid release during sustained visceral pain: a [11C]carfentanil PET study.
    Ly HG; Dupont P; Geeraerts B; Bormans G; Van Laere K; Tack J; Van Oudenhove L
    Pain; 2013 Oct; 154(10):2072-2077. PubMed ID: 23792286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort.
    Mick I; Myers J; Stokes PR; Erritzoe D; Colasanti A; Bowden-Jones H; Clark L; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Nutt DJ; Lingford-Hughes AR
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2069-74. PubMed ID: 24807268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute acetate administration increases endogenous opioid levels in the human brain: A [
    Ashok AH; Myers J; Frost G; Turton S; Gunn RN; Passchier J; Colasanti A; Marques TR; Nutt D; Lingford-Hughes A; Howes OD; Rabiner EA
    J Psychopharmacol; 2021 May; 35(5):606-610. PubMed ID: 33406950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.
    Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Quelch D; Erritzoe D; Tziortzi AC; Reed LJ; Lingford-Hughes AR; Waldman AD; Schruers KR; Matthews PM; Gunn RN; Nutt DJ; Rabiner EA
    Biol Psychiatry; 2012 Sep; 72(5):371-7. PubMed ID: 22386378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization.
    Quelch DR; Katsouri L; Nutt DJ; Parker CA; Tyacke RJ
    J Cereb Blood Flow Metab; 2014 Oct; 34(10):1604-12. PubMed ID: 25005876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central μ-Opioidergic System Activation Evoked by Heavy and Severe-Intensity Cycling Exercise in Humans: a Pilot Study Using Positron Emission Tomography with 11C-Carfentanil.
    Hiura M; Sakata M; Ishii K; Toyohara J; Oda K; Nariai T; Ishiwata K
    Int J Sports Med; 2017 Jan; 38(1):19-26. PubMed ID: 28073122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge.
    Scott DJ; Stohler CS; Koeppe RA; Zubieta JK
    Synapse; 2007 Sep; 61(9):707-14. PubMed ID: 17559096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What to learn from in vivo opioidergic brain imaging?
    Sprenger T; Berthele A; Platzer S; Boecker H; Tölle TR
    Eur J Pain; 2005 Apr; 9(2):117-21. PubMed ID: 15737798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
    Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
    Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional mu opioid receptor regulation of sensory and affective dimensions of pain.
    Zubieta JK; Smith YR; Bueller JA; Xu Y; Kilbourn MR; Jewett DM; Meyer CR; Koeppe RA; Stohler CS
    Science; 2001 Jul; 293(5528):311-5. PubMed ID: 11452128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in endogenous opioid functional measures in chronic back pain.
    Martikainen IK; Peciña M; Love TM; Nuechterlein EB; Cummiford CM; Green CR; Harris RE; Stohler CS; Zubieta JK
    J Neurosci; 2013 Sep; 33(37):14729-37. PubMed ID: 24027273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
    Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
    Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK
    Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.